Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,645 questions in 107 reviews · Wounds
current versionsNo studies 651 · 39.6%Ungraded 84 · 5.1%Very low 554 · 33.7%Low 283 · 17.2%Moderate 64 · 3.9%High 9 · 0.5%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Dextranomer beads (autolytic) vs Eusol gauze Time to complete healing (days) · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer beads (autolytic) vs Eusol gauze Serious adverse events: life‐threatening/ hospitalisation · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Time to a clean wound bed ( · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | 1 study · 40 participants | Very low |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Proportion of wounds completely debrided · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Dextranomer paste (autolytic) vs 10% aqueous polyvinylpyrrolidone Rate of reduction in wound size · adults with surgical wounds Debridement for surgical wounds (2024) · Cochrane | no estimate extracted | NR | No studies |
Standard polyurethane plus tissue adhesive vs standard polyurethane Arterial catheter failure assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.44 [0.2, 0.98] | 2 studies · 165 participants | Very low |
Bordered polyurethane vs standard polyurethane Adverse events assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.33 [0.01, 7.87] | 1 study · 60 participants | Very low |
Standard polyurethane plus sutureless securement devices vs standard polyurethane Arterial catheter failureassessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.78 [0.4, 1.52] | 2 studies · 157 participants | Very low |
Standard polyurethane plus sutureless securement devices vs standard polyurethane Incidence of catheter‐related bloodstream infection assessed during catheter dwell or 48 hours after removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | no estimate extracted | 2 studies · 157 participants | Very low |
Standard polyurethane plus sutureless securement devices vs standard polyurethane Dislodgement assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.14 [0.01, 2.57] | 2 studies · 157 participants | Very low |
Standard polyurethane plus sutureless securement devices vs standard polyurethane Occlusion assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 1.94 [0.5, 7.48] | 2 studies · 157 participants | Very low |
Standard polyurethane plus sutureless securement devices vs standard polyurethane Adverse events assessed during catheter dwell and on product removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 1.94 [0.19, 20.24] | 2 studies · 157 participants | Very low |
Integrated securement dressings vs standard polyurethane Arterial catheter failureassessed during catheter dwell or 48 hours after removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 1.96 [0.8, 4.84] | 1 study · 105 participants | Low |
Integrated securement dressings vs standard polyurethane Incidence of catheter‐related bloodstream infectionassessed during catheter dwell or 48 hours after removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | no estimate extracted | 1 study · 105 participants | Low |
Integrated securement dressings vs standard polyurethane Dislodgement assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.33 [0.04, 3.04] | 1 study · 105 participants | Low |
Integrated securement dressings vs standard polyurethane Occlusion assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | no estimate extracted | 1 study · 105 participants | Low |
Standard polyurethane plus tissue adhesive vs standard polyurethane Incidence of catheter‐related bloodstream infection assessed during catheter dwell or 48 hours after removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | no estimate extracted | 2 studies · 165 participants | Very low |
Integrated securement dressings vs standard polyurethane Adverse events assessed during catheter dwell or on product removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.35 [0.01, 8.45] | 1 study · 105 participants | Low |
Standard polyurethane plus tissue adhesive vs standard polyurethane Dislodgement assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.54 [0.03, 9.62] | 2 studies · 165 participants | Very low |
Standard polyurethane plus tissue adhesive vs standard polyurethane Occlusion assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 1.2 [0.37, 3.91] | 2 studies · 165 participants | Very low |
Standard polyurethane plus tissue adhesive vs standard polyurethane Adverse events assessed during catheter dwell and on product removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.89 [0.09, 8.33] | 2 studies · 165 participants | Very low |
Bordered polyurethane vs standard polyurethane Arterial catheter failureassessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.67 [0.21, 2.13] | 1 study · 60 participants | Very low |
Bordered polyurethane vs standard polyurethane Incidence of catheter‐related bloodstream infectionassessed during catheter dwell or 48 hours after removal · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 3.05 [0.12, 74.45] | 2 studies · 572 participants | Low |
Bordered polyurethane vs standard polyurethane Dislodgement assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.75 [0.17, 3.22] | 2 studies · 572 participants | Low |
Bordered polyurethane vs standard polyurethane Occlusion assessed during catheter dwell · people with arterial catheter dressing and securement Dressings and securement devices to prevent complications for peripheral arterial catheters (2024) · Cochrane | RR 0.8 [0.6, 1.07] | 2 studies · 572 participants | Low |
Doxepin cream vs oral antihistamine Change in burn‐related pruritus (VAS) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 2 studies · 49 participants | Low |
Ondansetron vs diphenhydramine (antihistamine) Change in burn‐related pruritus (NAS) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 1 study · 38 participants | Moderate |
Ondansetron vs diphenhydramine (antihistamine) Adverse events · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Ondansetron vs diphenhydramine (antihistamine) Pain · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Enalapril ointment vs placebo Change in burn‐related pruritus (Scoring table for itching) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 1 study · 60 participants | Moderate |
Enalapril ointment vs placebo Adverse events · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Enalapril ointment vs placebo Pain · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Massage therapy vs standard care Change in burn‐related pruritus Itching scale ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 2 studies · 166 participants | Low |
Massage therapy vs standard care Adverse events · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Massage therapy vs standard care Pain VAS for pain ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 2 studies · 166 participants | Low |
Extracorporeal shock wave therapy vs sham Change in burn‐related pruritus NRS ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 2 studies · 91 participants | Low |
Doxepin cream vs oral antihistamine Adverse events (somnolence) · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | RR 0.64 [0.32, 1.25] | 1 study · 24 participants | Very low |
Extracorporeal shock wave therapy vs sham Adverse events · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Extracorporeal shock wave therapy vs sham Pain Pressure pain threshold (PPT) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | MD 2.96 [1.76, 4.16] | 1 study · 45 participants | Low |
Pulsed high‐intensity laser vs placebo laser Change in burn‐related pruritus Itch Severity Scale (ISS) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 1 study · 49 participants | Moderate |
Pulsed high‐intensity laser vs placebo laser Adverse events · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Pulsed high‐intensity laser vs placebo laser Pain VAS ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 1 study · 49 participants | Moderate |
Doxepin cream vs oral antihistamine Pain · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Gabapentin vs cetirizine (antihistamine) Change in burn‐related pruritus (VAS) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
Gabapentin vs cetirizine (antihistamine) Adverse events (somnolence) · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | RR 0.02 [0, 0.38] | 1 study · 40 participants | Low |
Gabapentin vs cetirizine (antihistamine) Pain · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Pregabalin vs cetirizine with pheniramine maleate (antihistamine) Change in burn‐related pruritus (VAS) ( · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | 1 study · 40 participants | Low |
Pregabalin vs cetirizine with pheniramine maleate (antihistamine) Adverse events (drowsiness) · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | RR 0.04 [0, 0.69] | 1 study · 40 participants | Low |
Pregabalin vs cetirizine with pheniramine maleate (antihistamine) Pain · people with postburn pruritus Interventions for postburn pruritus (2024) · Cochrane | no estimate extracted | NR | No studies |
Pressure‐garment therapy (PGT) vs no treatment/lanolin Scar improvement (VSS) (0–13, higher score = more severe scarring) · people with burn wounds likely to develop hypertrophic scarring Pressure‐garment therapy for preventing hypertrophic scarring after burn injury (2024) · Cochrane | no estimate extracted | 3 studies · 187 participants | Very low |